Vascular endothelial growth factor (VEGF) is key in ocular neovascularization and related to diseases such as retinal vein obstruction, diabetic retinopathy (DR), neovascular glaucoma, age-related macular degeneration (AMD), and retinopathy of prematurity (ROP). Here, VEGFA is linked to diabetic retinopathy.